antibody Archives -

Sanofi has agreed another deal to flesh out its R&D pipeline, paying IGM Biosciences $150 million upfront to

Sanofi’s R&D platform building continues with $6bn-plus IGM deal

https://pharmaphorum.com/news/sanofis-rd-platform-building-continues-with-6bn-plus-igm-deal/

Coronavirus pharma news roundup 27/03/2020

Market Access/ News/ News

FDA restricts GSK’s Xevudy due to lower efficacy against BA.2

Phil Taylor antibody, AstraZeneca, coronavirus, COVID-19, Evusheld, GlaxoSmithKline, Vir Biotechnology 0 Comment

GlaxoSmithKline and Vir’s Xevudy has become the latest COVID-19 antibody therapy to have its use restricted by the

FDA restricts GSK’s Xevudy due to lower efficacy against BA.2

https://pharmaphorum.com/news/fda-restricts-gsks-xevudy-due-to-lower-efficacy-against-ba-2/

Market Access/ News/ News

FDA sets August decision date for Provention’s type 1 diabetes drug

Phil Taylor antibody, fda, metabolic disease, Provention Bio, teplizumab, type 1 diabetes 0 Comment

Shares in Provention Bio cratered last July when the FDA turned down its marketing application for type 1

FDA sets August decision date for Provention’s type 1 diabetes drug

https://pharmaphorum.com/news/fda-sets-august-decision-date-for-proventions-type-1-diabetes-drug/

Market Access/ News/ News

Lilly bags US okay for rival to GSK’s COVID-19 drug Xevudy

Phil Taylor antibody, bebtelovimab, coronavirus, COVID-19, Eli Lilly, GlaxoSmithKline, xevudy 0 Comment

Eli Lilly has been granted an emergency use authorisation from the FDA for bebtelovimab, its second COVID-19 antibody

Lilly bags US okay for rival to GSK’s COVID-19 drug Xevudy

https://pharmaphorum.com/news/lilly-bags-us-okay-for-rival-to-gsks-covid-19-drug-xevudy/

News/ News/ Sales and Marketing

FDA bans use of Lilly, Regeneron COVID drugs due to Omicron

Phil Taylor antibody, coronavirus, COVID-19, Eli Lilly, Regeneron, Sales and Marketing 0 Comment

The FDA has limited the use of COVID-19 antibody therapies developed by Eli Lilly and Regeneron, on the

FDA bans use of Lilly, Regeneron COVID drugs due to Omicron

https://pharmaphorum.com/news/fda-bans-use-of-lilly-regeneron-covid-drugs-due-to-omicron/

Market Access/ News/ News

AZ’s antibody first to be cleared by FDA for COVID prevention

Phil Taylor antibody, AstraZeneca, AZD7442, coronavirus, COVID-19, Evusheld, fda 0 Comment

AstraZeneca’s antibody cocktail for COVID-19, now called Evusheld, has become the first drug in the class to be

AZ’s antibody first to be cleared by FDA for COVID prevention

https://pharmaphorum.com/news/azs-antibody-first-to-be-cleared-by-fda-for-covid-prevention/

Market Access/ News

MHRA okays GSK’s Xevudy as data suggest it works against Omicron

Phil Taylor antibody, coronavirus, COVID-19, GlaxoSmithKline, MHRA, regulatory approval, sotrovimab, Vir Biotechnology, xevudy 0 Comment

The UK medicines regulator has approved GlaxoSmithKline and Vir Biotech’s antibody for COVID-19, Xevudy, which has been shown

MHRA okays GSK’s Xevudy as data suggest it works against Omicron

https://pharmaphorum.com/market-access-2/mhra-okays-gsks-xevudy-as-data-suggest-it-works-against-omicron/

News/ News/ Sales and Marketing

US signs $1bn order for GSK, Vir’s COVID-19 antibody

Phil Taylor antibody, COVID-19, GlaxoSmithKline, sotrovimab, Vir Biotechnology, xevudy 0 Comment

The US has made a sizeable order for GlaxoSmithKline and Vir Biotechnology’s antibody-based COVID-19 treatment sotrovimab said to

US signs $1bn order for GSK, Vir’s COVID-19 antibody

https://pharmaphorum.com/news/us-signs-1bn-order-for-gsk-virs-covid-19-antibody/

Market Access/ News/ News

COVID antibodies from Roche, Celltrion backed for approval in EU

Phil Taylor antibody, Celltrion, CHMP, coronavirus, COVID-19, Regeneron, Roche 0 Comment

The EMA’s human medicines committee has recommended approval of Roche’s Ronapreve and Celltrion’s Regkirona for use in COVID-19,

COVID antibodies from Roche, Celltrion backed for approval in EU

https://pharmaphorum.com/news/first-covid-antibodies-from-roche-celltrion-backed-in-eu/

Trending

antibody

Login